The ascendancy of Viagra and its influence on the pharmaceutical landscape presents a complicated question for traders. While the first sales data were astounding, the patent has lapsed, leading to a flood of off-brand alternatives that are reducing profit. In addition, the sector is facing challenges related to aging trends and evolving healthc… Read More